Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 15 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 60 most recent Form 4 transactions.
| Sep 3 | MAZE | Maze Therapeutics, Inc. | SSELL | 5,130 | $26.01 | $133.4K | -34.4% | Open the original filing on SEC.gov |
| Sep 2 | MAZE | Maze Therapeutics, Inc. | SSELL | 625 | $27.12 | $17K | -4.0% | Open the original filing on SEC.gov |
| Sep 2 | MAZE | Maze Therapeutics, Inc. | SSELL | 4,481 | $26.38 | $118.2K | -22.4% | Open the original filing on SEC.gov |
| Sep 1 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 1 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 16,141 | — | — | — | Open the original filing on SEC.gov |
| Sep 1 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 1 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 16,141 | $26.36 | $425.5K | -100.0% | Open the original filing on SEC.gov |
| Sep 1 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 16,141 | $10.42 | $168.2K | — | Open the original filing on SEC.gov |
| Aug 13 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 16,142 | — | — | — | Open the original filing on SEC.gov |
| Aug 13 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 16,142 | $27.61 | $445.6K | -100.0% | Open the original filing on SEC.gov |
| Aug 13 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 16,142 | $10.42 | $168.2K | — | Open the original filing on SEC.gov |
| Jul 1 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 14,609 | — | — | — | Open the original filing on SEC.gov |
| Jul 1 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 1,200 | $30.34 | $36.4K | -100.0% | Open the original filing on SEC.gov |
| Jul 1 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 13,409 | $29.87 | $400.5K | -91.8% | Open the original filing on SEC.gov |
| Jul 1 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 14,609 | $10.42 | $152.2K | — | Open the original filing on SEC.gov |
| Jun 1 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 14,853 | — | — | — | Open the original filing on SEC.gov |
| Jun 1 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 1,600 | $26.36 | $42.2K | -100.0% | Open the original filing on SEC.gov |
| Jun 1 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 13,253 | $25.57 | $338.9K | -89.2% | Open the original filing on SEC.gov |
| Jun 1 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 14,853 | $10.42 | $154.8K | — | Open the original filing on SEC.gov |
| May 14 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| May 14 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 15,000 | $26.22 | $393.4K | -100.0% | Open the original filing on SEC.gov |
| May 14 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 15,000 | $10.42 | $156.3K | — | Open the original filing on SEC.gov |
| Apr 1 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 300 | $31.07 | $9.3K | -100.0% | Open the original filing on SEC.gov |
| Apr 1 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 3,348 | $30.06 | $100.6K | -91.8% | Open the original filing on SEC.gov |
| Apr 1 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 11,352 | $29.24 | $331.9K | -75.7% | Open the original filing on SEC.gov |
| Apr 1 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 15,000 | $10.42 | $156.3K | — | Open the original filing on SEC.gov |
| Mar 20 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 20 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 5,044 | $50.02 | $252.3K | -100.0% | Open the original filing on SEC.gov |
| Mar 20 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 3,795 | $49.32 | $187.2K | -42.9% | Open the original filing on SEC.gov |
| Mar 20 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 6,161 | $48.20 | $297K | -41.1% | Open the original filing on SEC.gov |
| Mar 20 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 15,000 | $10.42 | $156.3K | — | Open the original filing on SEC.gov |
| Mar 10 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 10 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 348 | $51.02 | $17.8K | -100.0% | Open the original filing on SEC.gov |
| Mar 10 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 29,652 | $50.45 | $1.5M | -98.8% | Open the original filing on SEC.gov |
| Mar 10 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 30,000 | $10.42 | $312.6K | — | Open the original filing on SEC.gov |
| Mar 2 | MAZE | Maze Therapeutics, Inc. | AGRANT◆ | 24,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | MAZE | Maze Therapeutics, Inc. | AGRANT◆ | 48,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 100 | $47.23 | $4.7K | -100.0% | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 5,936 | $46.37 | $275.3K | -98.3% | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 8,364 | $45.89 | $383.8K | -58.1% | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 600 | $44.21 | $26.5K | -4.0% | Open the original filing on SEC.gov |
| Feb 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 15,000 | $10.42 | $156.3K | — | Open the original filing on SEC.gov |
| Jan 7 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 25,156 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 25,156 | $40.20 | $1M | -100.0% | Open the original filing on SEC.gov |
| Jan 7 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 25,156 | $10.42 | $262.1K | — | Open the original filing on SEC.gov |
| Jan 5 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 412 | — | — | — | Open the original filing on SEC.gov |
| Jan 5 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 412 | $40.00 | $16.5K | -100.0% | Open the original filing on SEC.gov |
| Jan 5 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 412 | $10.42 | $4.3K | — | Open the original filing on SEC.gov |
| Jan 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 4,432 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 4,432 | $40.43 | $179.2K | -100.0% | Open the original filing on SEC.gov |
| Jan 2 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 4,432 | $10.42 | $46.2K | — | Open the original filing on SEC.gov |
| Dec 29, 2025 | MAZE | Maze Therapeutics, Inc. | MEXER◷◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 29, 2025 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 17,200 | $40.93 | $703.9K | -100.0% | Open the original filing on SEC.gov |
| Dec 29, 2025 | MAZE | Maze Therapeutics, Inc. | SSELL◷ | 27,800 | $40.34 | $1.1M | -61.8% | Open the original filing on SEC.gov |
| Dec 29, 2025 | MAZE | Maze Therapeutics, Inc. | MEXER◷ | 45,000 | $10.42 | $468.9K | — | Open the original filing on SEC.gov |
| Sep 22, 2025 | MAZE | Maze Therapeutics, Inc. | AGRANT◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |